Tivic Health Systems Q2 EPS $(0.32) Up From $(7.16) YoY, Sales $140.00K Down From $161.00K YoY
Portfolio Pulse from Benzinga Newsdesk
Tivic Health Systems (NASDAQ:TIVC) reported Q2 EPS of $(0.32), a significant improvement from $(7.16) YoY. However, sales decreased by 13.04% to $140.00K from $161.00K YoY.
August 14, 2024 | 8:32 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Tivic Health Systems reported a significant improvement in EPS to $(0.32) from $(7.16) YoY, but experienced a 13.04% decline in sales to $140.00K.
The significant improvement in EPS is a positive sign, indicating better cost management or operational efficiency. However, the decline in sales is a concern, suggesting potential issues with market demand or competition. The mixed results are likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100